# Plasma-based Colorectal Cancer Screening Research & Development

> **NCT04027790** · — · COMPLETED · sponsor: **Epigenomics, Inc** · enrollment: 354 (actual)

## Conditions studied

- Colo-rectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Epi proColon

## Key facts

- **NCT ID:** NCT04027790
- **Lead sponsor:** Epigenomics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-03
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 354 (ACTUAL)
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04027790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04027790, "Plasma-based Colorectal Cancer Screening Research & Development". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04027790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*